Top compounds associated with response to MRPL44


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.003
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.003
mRNA Roscovitine GDSC1000 pan-cancer AAC 0.17 0.003
mRNA Vorinostat gCSI pan-cancer AAC 0.15 0.003
mRNA ML210 CTRPv2 pan-cancer AAC -0.1 0.004
mRNA tandutinib CTRPv2 pan-cancer AAC 0.11 0.004
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.004
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.096 0.005
mRNA AZD8055 GDSC1000 pan-cancer AAC 0.1 0.005
Download CSV